The leader sequence triggers and enhances several functions of clusterin and is instrumental in the progression of human prostate cancer <i>in vivo</i> and <i>in vitro</i>
Qiang Zhang(Henan University of Science and Technology), Chung Lee(Taipei Tzu Chi Hospital), Borko Jovanovic(Northwestern University), Shilajit Kundu(Northwestern University), Ximing J. Yang(Shenyang Aerospace University), Yinglu Guo(Ministry of Education of the People's Republic of China), Li‐Li Liang(Peking University), Wei Zhou(Broad Institute), Dianqi Xin(Peking University), Norm D. Smith(Caris Life Sciences (United States)), Michael Pins(Northwestern University), Thomas L. Jang
Cited by 23
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Transfusion guidelines for neonates and older children
|British Journal of Haematology|2004|371
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256
The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells
|Biomaterials|2013|223